Cephalexin - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for cephalexin and what is the scope of freedom to operate?
Cephalexin
is the generic ingredient in five branded drugs marketed by Alkem Labs Ltd, Anda Repository, Apothecon, Aurobindo Pharma, Barr, Belcher Pharms, Chartwell Rx, Facta Farma, Hikma, Ivax Sub Teva Pharms, Lupin, Purepac Pharm, Stevens J, Sun Pharm Inds (in), Sun Pharm Inds Ltd, Teva, Yoshitomi, Pragma, Hikma Pharms, Vitarine, Yung Shin Pharm, Ranbaxy Labs Ltd, and Lilly, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-nine drug master file entries for cephalexin. Thirty-five suppliers are listed for this compound.
Summary for cephalexin
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 23 |
NDAs: | 56 |
Drug Master File Entries: | 29 |
Finished Product Suppliers / Packagers: | 35 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Clinical Trials: | 61 |
Patent Applications: | 6,614 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for cephalexin |
Drug Sales Revenues: | Drug sales revenues for cephalexin |
What excipients (inactive ingredients) are in cephalexin? | cephalexin excipients list |
DailyMed Link: | cephalexin at DailyMed |
Recent Clinical Trials for cephalexin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Network of Canadian Emergency Researchers (NCER) | Phase 4 |
Western Sydney Local Health District | Phase 2 |
Centre Of Research Excellence in Tuberculosis Control | Phase 2 |
Pharmacology for cephalexin
Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for cephalexin
US Patents and Regulatory Information for cephalexin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Facta Farma | CEPHALEXIN | cephalexin | FOR SUSPENSION;ORAL | 062117-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lupin | CEPHALEXIN | cephalexin | CAPSULE;ORAL | 065229-002 | Nov 25, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Ranbaxy Labs Ltd | PANIXINE DISPERDOSE | cephalexin | TABLET, FOR SUSPENSION;ORAL | 065100-002 | Sep 11, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Chartwell Rx | CEPHALEXIN | cephalexin | FOR SUSPENSION;ORAL | 065326-002 | Jul 10, 2006 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Anda Repository | CEPHALEXIN | cephalexin | CAPSULE;ORAL | 065248-001 | Jun 28, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pragma | KEFLEX | cephalexin | FOR SUSPENSION;ORAL | 050406-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.